Understanding how changes in the nuclear envelope can lead to liver cancer

Nuclear envelope and predisposition to hepatic neoplasia

NIH-funded research Hackensack University Medical Center · NIH-10892309

This study is looking at how chronic liver diseases, especially nonalcoholic steatohepatitis, can raise the chances of developing liver cancer, and it focuses on a protein called LAP1 to understand how changes in this protein might lead to cancer in people with liver issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHackensack University Medical Center NIH-funded
Lab location1 site (Hackensack, United States)
Project IDNIH-10892309 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which chronic liver diseases, particularly nonalcoholic steatohepatitis, increase the risk of liver cancer. It focuses on a protein called lamina-associated polypeptide 1 (LAP1) that plays a crucial role in liver cell differentiation and metabolism. By studying how alterations in LAP1 expression affect liver cells, the research aims to uncover genetic changes that predispose individuals to hepatocellular carcinoma (HCC). This could lead to new insights into liver cancer development and potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with chronic liver diseases, especially those diagnosed with nonalcoholic steatohepatitis.

Not a fit: Patients without chronic liver diseases or those who do not have a predisposition to liver cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide new strategies for preventing or treating liver cancer in patients with chronic liver diseases.

How similar studies have performed: Previous research has shown promising results in understanding the genetic mechanisms of liver cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

Hackensack, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer Causing AgentsCancer GenesCancer-Promoting GeneCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.